Nothing Special   »   [go: up one dir, main page]

ES2540327T3 - Derivados de 8-hidroxiquinolin-7-carboxamida terciaria y usos de los mismos - Google Patents

Derivados de 8-hidroxiquinolin-7-carboxamida terciaria y usos de los mismos Download PDF

Info

Publication number
ES2540327T3
ES2540327T3 ES10800763.4T ES10800763T ES2540327T3 ES 2540327 T3 ES2540327 T3 ES 2540327T3 ES 10800763 T ES10800763 T ES 10800763T ES 2540327 T3 ES2540327 T3 ES 2540327T3
Authority
ES
Spain
Prior art keywords
nitrogen
sulfur
oxygen
taken together
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10800763.4T
Other languages
English (en)
Inventor
Stefania Gagliardi
Simone Del Sordo
Federico Mailland
Michela Legora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polichem SA
Original Assignee
Polichem SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42026678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2540327(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem SA filed Critical Polichem SA
Application granted granted Critical
Publication of ES2540327T3 publication Critical patent/ES2540327T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compuesto de fórmula general (I) o una sal farmacéuticamente aceptable del mismo**Fórmula** en donde R2 y R3, independientemente uno de otro, se seleccionan de: a) -C1-C6 alquilo, con la condición de que R2 y R3 no son ambos metilo, b) -(CH2)n-arilo, 4-halo-bencilo o 4-halo-fenilo , c) -(CH2)n-cicloalquilo, d) -(CH2)n-heterociclo, e) -(CH2)n-OR6, f) -(CH2)n-CN, g) -(CH2)n-NR4R5, h) tomados junto con el átomo de nitrógeno al que están unidos para formar un heteromonociclo de 5 a 8 miembros que contiene de uno a tres heteroátomos seleccionados del grupo que consiste de nitrógeno, oxígeno y azufre, o i) tomados junto con el átomo de nitrógeno al que están unidos para formar (i) un heteromonociclo de 5 a 8 miembros el cual está fusionado a uno o dos anillos saturados o insaturados o a otros heterociclos que contienen de uno a tres heteroátomos seleccionados del grupo que consiste de nitrógeno, oxígeno y azufre; o (ii) una dihidroquinolina sustituida por halo y/o hidroxi; en donde R4 y R5, independientemente uno de otro, se seleccionan de: a) -H, b) -C1-C6 alquilo, c) -(CH2)n-arilo, d) -(CH2)n-cicloalquilo, e) -(CH2)n-heterociclo, f) -(CH2)n-OR6, g) -(CH2)n-CN, h) tomados junto con el átomo de nitrógeno al que están unidos para formar un heteromonociclo de 5 a 8 miembros que contiene de uno a tres heteroátomos seleccionados del grupo que consiste de nitrógeno, oxígeno y azufre, o j) tomados junto con el átomo de nitrógeno al que están unidos para formar un heteromonociclo de 5 a 8 miembros el cual está fusionado a uno o dos anillos saturados o insaturados o a otros heterociclos que contienen de uno a tres heteroátomos seleccionados del grupo que consiste de nitrógeno, oxígeno y azufre; o en donde R6 es seleccionado de: a) -H, b) -C1-C6 alquilo, c) -(CH2)n-arilo, d) -(CH2)n-cicloalquilo, o e) -(CH2)n-heterociclo,; y en donde n es un entero de 0 a 6.
ES10800763.4T 2009-12-29 2010-12-28 Derivados de 8-hidroxiquinolin-7-carboxamida terciaria y usos de los mismos Active ES2540327T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09180902A EP2345643A1 (en) 2009-12-29 2009-12-29 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
EP09180902 2009-12-29
PCT/EP2010/070790 WO2011080264A1 (en) 2009-12-29 2010-12-28 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof

Publications (1)

Publication Number Publication Date
ES2540327T3 true ES2540327T3 (es) 2015-07-09

Family

ID=42026678

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10800763.4T Active ES2540327T3 (es) 2009-12-29 2010-12-28 Derivados de 8-hidroxiquinolin-7-carboxamida terciaria y usos de los mismos

Country Status (37)

Country Link
US (1) US8729098B2 (es)
EP (2) EP2345643A1 (es)
JP (1) JP5808754B2 (es)
KR (1) KR101666505B1 (es)
CN (2) CN105384685A (es)
AU (1) AU2010338267B2 (es)
BR (1) BR112012015728A2 (es)
CA (1) CA2783213C (es)
CL (1) CL2012001757A1 (es)
CY (1) CY1116493T1 (es)
DK (1) DK2519505T3 (es)
DO (1) DOP2012000186A (es)
EA (1) EA025563B1 (es)
EC (1) ECSP12012007A (es)
ES (1) ES2540327T3 (es)
GE (1) GEP20156244B (es)
GT (1) GT201200216A (es)
HK (1) HK1178526A1 (es)
HR (1) HRP20150749T1 (es)
HU (1) HUE027220T2 (es)
IL (1) IL220427A (es)
MA (1) MA33829B1 (es)
MX (1) MX2012007748A (es)
MY (1) MY161869A (es)
NI (1) NI201200114A (es)
NZ (1) NZ600788A (es)
PE (1) PE20130179A1 (es)
PL (1) PL2519505T3 (es)
PT (1) PT2519505E (es)
RS (1) RS54096B1 (es)
SG (1) SG181586A1 (es)
SI (1) SI2519505T1 (es)
SM (1) SMT201500182B (es)
TN (1) TN2012000320A1 (es)
UA (1) UA107949C2 (es)
WO (1) WO2011080264A1 (es)
ZA (1) ZA201204347B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives
CA2857262A1 (en) * 2012-02-24 2013-08-29 F. Hoffmann-La Roche Ag Antiviral compounds
ES2749512T3 (es) 2012-10-02 2020-03-20 Inst Nat Sante Rech Med Derivados de tetrahidroquinolina y su uso como inhibidores de Epac
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
WO2022066759A1 (en) 2020-09-22 2022-03-31 Milwaukee Electric Tool Corporation Staple and staple collation
USD976093S1 (en) 2020-09-22 2023-01-24 Milwaukee Electric Tool Corporation Staple collation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US326328A (en) 1885-09-15 Broiler
US326330A (en) 1885-09-15 Harness-support
DE540842C (de) 1930-08-06 1931-12-28 Chinosol Fabrik Akt Ges Verfahren zur Darstellung der 8-Acetyloxychinolin-7-carbonsaeure
CN1180995A (zh) 1995-04-08 1998-05-06 巴斯福股份公司 防治有害真菌的方法
WO1997017973A1 (en) * 1995-11-13 1997-05-22 Smithkline Beecham Corporation Hemoregulatory compounds
WO1998011073A1 (en) 1996-09-10 1998-03-19 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
WO1999016747A1 (fr) * 1997-09-30 1999-04-08 Daiichi Pharmaceutical Co., Ltd. Derives sulfonyle
JP2001294572A (ja) * 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
BR0114610A (pt) 2000-10-12 2005-12-13 Merck & Co Inc Composto, uso do mesmo, e, composição farmacêutica
AU2002215328B2 (en) 2000-10-12 2005-11-17 Merck Sharp & Dohme Corp. Aza- and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors
HUP0400175A2 (en) 2001-03-01 2007-07-30 Shionogi & Co Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity, their use and pharmaceutical compositions containing them
AU2003257822A1 (en) 2002-08-13 2004-04-30 Shionogi And Co., Ltd. Heterocyclic compound having hiv integrase inhibitory activity
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
FR2889192A1 (fr) * 2005-07-27 2007-02-02 Cytomics Systems Sa Composes antifongiques, compositions contenant ces composes et leurs utilisations
EP2059305A2 (en) * 2006-07-26 2009-05-20 Novartis Ag Inhibitors of undecaprenyl pyrophosphate synthase
WO2009140215A2 (en) * 2008-05-11 2009-11-19 Geraghty, Erin Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
PT2499139E (pt) * 2009-11-10 2014-02-10 Pfizer Inibidores de n1-pirazolospirocetona acetil-coa carboxilase
WO2011075630A1 (en) * 2009-12-18 2011-06-23 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
EP2345642A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
EP2345641A1 (en) * 2009-12-29 2011-07-20 Polichem S.A. New secondary 8-hydroxyquinoline-7-carboxamide derivatives

Also Published As

Publication number Publication date
HUE027220T2 (hu) 2016-10-28
MY161869A (en) 2017-05-15
PE20130179A1 (es) 2013-02-24
RS54096B1 (en) 2015-10-30
EA025563B1 (ru) 2017-01-30
CA2783213A1 (en) 2011-07-07
CN105384685A (zh) 2016-03-09
CA2783213C (en) 2017-09-12
UA107949C2 (en) 2015-03-10
PL2519505T3 (pl) 2015-11-30
KR20120101563A (ko) 2012-09-13
DOP2012000186A (es) 2013-01-15
CL2012001757A1 (es) 2013-03-22
JP5808754B2 (ja) 2015-11-10
EA201270670A1 (ru) 2013-03-29
AU2010338267A1 (en) 2012-07-19
WO2011080264A1 (en) 2011-07-07
US20120309751A1 (en) 2012-12-06
US8729098B2 (en) 2014-05-20
SMT201500182B (it) 2015-09-07
CY1116493T1 (el) 2017-03-15
JP2013515755A (ja) 2013-05-09
MA33829B1 (fr) 2012-12-03
EP2519505A1 (en) 2012-11-07
EP2519505B1 (en) 2015-05-27
CN102686566A (zh) 2012-09-19
NZ600788A (en) 2013-08-30
AU2010338267B2 (en) 2014-03-27
MX2012007748A (es) 2012-08-03
TN2012000320A1 (en) 2013-12-12
HK1178526A1 (en) 2013-09-13
GEP20156244B (en) 2015-02-10
KR101666505B1 (ko) 2016-10-14
DK2519505T3 (en) 2015-06-29
ZA201204347B (en) 2013-09-25
SG181586A1 (en) 2012-07-30
NI201200114A (es) 2013-04-22
HRP20150749T1 (hr) 2015-08-14
EP2345643A1 (en) 2011-07-20
BR112012015728A2 (pt) 2019-09-24
AU2010338267A2 (en) 2012-07-26
ECSP12012007A (es) 2012-08-31
SI2519505T1 (sl) 2015-08-31
PT2519505E (pt) 2015-09-03
GT201200216A (es) 2014-12-26
IL220427A (en) 2015-04-30

Similar Documents

Publication Publication Date Title
ES2540327T3 (es) Derivados de 8-hidroxiquinolin-7-carboxamida terciaria y usos de los mismos
UY30296A1 (es) Compuestos fenil amido heterociclicos condensados
AR112834A1 (es) Derivados de rapamicina
PE20160501A1 (es) Derivados de quinolizina sustituidos utiles como inhibidores de integrasa del vih
BR112017003658A2 (pt) composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica.
AR077695A1 (es) Derivados de pirimidina como inhibidores del factor ixa
UY30334A1 (es) Derivados de triazolopirazina
PE20151781A1 (es) Piridonamidas como moduladores de canales de sodio
AR079226A1 (es) Espiroindolinona- pirrolidinas, procesos de preparacion y uso de los mismos para el tratamiento y profilaxis del cancer
ECSP099269A (es) Compuestos de fenilurea como inhibidores de epóxido hidrolasa soluble
AR089774A1 (es) Derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
AR079205A1 (es) Morfolinotiazoles como moduladores alostericos positivos alfa 7
AR094876A1 (es) Derivados de ácido betulínico modificados con alquilo c-3 y alquenilo
CO6300861A2 (es) Compuestos inhibidores de dipeptidil peptidasa iv metodos de preparacion de los mismos y composiciones farmaceuticas que los contienen como agentes activos
MY148482A (en) Heterocyclic compound and pharmaceutical composition thereof
EA201991349A1 (ru) Тетрациклические гетероциклические соединения, полезные в качестве ингибиторов интегразы вич
CO2019004978A2 (es) Compuestos terapéuticos y métodos para utilizarlos
AR082111A1 (es) Furopiridinas o tienopiridinas condensadas, composiciones farmaceuticas que las contienen utiles para tratar trastornos psicoticos y del sistema nervioso central, y metodo de preparacion de las mismas
AR087470A1 (es) Derivados imidazolicos bifenilenicos y composiciones farmaceuticas que los contienen
AR090474A1 (es) Compuestos de tetrahidropirrolotiazina
AR109735A1 (es) Método para la síntesis de derivado de 3-fenil-2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno e isómero óptico del mismo
AR089020A1 (es) Agentes de reversion anticoagulante
MX2020004842A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
PH12014501181A1 (en) N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics